(Q42256616)

19 October 2017

Significance of a fall in serum CEA concentration in patients treated with cytotoxic chemotherapy for disseminated colorectal cancer (English)

1 reference

19 October 2017

1 reference

1 reference

Allen-Mersh TG

1

1 reference

19 October 2017

Kemeny N

2

1 reference

19 October 2017

Niedzwiecki D

3

1 reference

19 October 2017

Shurgot B

4

1 reference

19 October 2017

Daly JM

5

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 December 1987

1 reference

19 October 2017

1 reference

19 October 2017

28

1 reference

19 October 2017

12

1 reference

19 October 2017

1625-1629

1 reference

Prognostic factors in advanced colorectal carcinoma. Importance of lactic dehydrogenase level, performance status, and white blood cell count

19 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433939

Prospective randomised trial of early cytotoxic therapy for recurrent colorectal carcinoma detected by serum CEA

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433939

CEA Monitoring of Palliative Treatment for Colorectal Carcinoma

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433939

Tables of power for the F-test for comparing two exponential survival distributions

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433939

Nonparametric confidence limits for survival probabilities and median survival time.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433939

Analysis of survival by tumor response.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433939

Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433939

Carcinoembryonic antigen (CEA) as a monitor of chemotherapy in disseminated colorectal cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1433939

The value of serial carcinoembryonic antigen (CEA) in predicting response rate and survival of patients with gastrointestinal cancer treated with chemotherapy. A Southwest oncology group study

29 May 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3428690

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Criteria for monitoring carcinoembryonic antigen: variability of sequential assays at elevated levels

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3428690

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/GUT.28.12.1625

1 reference

19 October 2017

1 reference

19 October 2017

PubMed publication ID

3428690

1 reference